Literature DB >> 17561601

Rapid reduction of antihypertensive medications and insulin requirements after tracheostomy in a patient with severe obstructive sleep apnea syndrome.

Arvind Bhimaraj1, Navasuma Havaligi, Siva Ramachandran.   

Abstract

We report a patient with severe obstructive sleep apnea syndrome, diabetes mellitus, and hypertension, with postoperative complications following tracheostomy. His stormy postoperative course is presented with emphasis on glycemic control and hypertension. We present a cautionary tale of a significant reduction in medications to control blood pressure and hyperglycemia following tracheostomy for severe OSA. The severe reduction in blood pressure and hypoglycemia could mimic sepsis and clinicans need to be vigilant to these dramatic effects following tracheostomy and appropriately adjust baseline medications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561601      PMCID: PMC2564779     

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  16 in total

Review 1.  Epidemiology of obstructive sleep apnea: a population health perspective.

Authors:  Terry Young; Paul E Peppard; Daniel J Gottlieb
Journal:  Am J Respir Crit Care Med       Date:  2002-05-01       Impact factor: 21.405

Review 2.  Sleep-disordered breathing, glucose intolerance, and insulin resistance.

Authors:  Naresh M Punjabi; Murtuza M Ahmed; Vsevolod Y Polotsky; Brock A Beamer; Christopher P O'Donnell
Journal:  Respir Physiol Neurobiol       Date:  2003-07-16       Impact factor: 1.931

3.  Role of endothelin in intermittent hypoxia-induced hypertension.

Authors:  N L Kanagy; B R Walker; L D Nelin
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

4.  Obstructive sleep apnea syndrome and tracheostomy. Long-term follow-up experience.

Authors:  C Guilleminault; F B Simmons; J Motta; J Cummiskey; M Rosekind; J S Schroeder; W C Dement
Journal:  Arch Intern Med       Date:  1981-07

5.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea.

Authors:  Ambika R Babu; James Herdegen; Leon Fogelfeld; Susan Shott; Theodore Mazzone
Journal:  Arch Intern Med       Date:  2005-02-28

6.  Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome.

Authors:  Igor A Harsch; Simin Pour Schahin; Martin Radespiel-Tröger; Oliver Weintz; Holger Jahreiss; Florian S Fuchs; Gunther H Wiest; Eckhart G Hahn; Tobias Lohmann; Peter C Konturek; Joachim H Ficker
Journal:  Am J Respir Crit Care Med       Date:  2003-09-25       Impact factor: 21.405

Review 7.  Upper airway surgery for obstructive sleep apnea.

Authors:  Aaron E Sher
Journal:  Sleep Med Rev       Date:  2002-06       Impact factor: 11.609

8.  Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study.

Authors:  Naresh M Punjabi; Eyal Shahar; Susan Redline; Daniel J Gottlieb; Rachel Givelber; Helaine E Resnick
Journal:  Am J Epidemiol       Date:  2004-09-15       Impact factor: 4.897

Review 9.  Obstructive sleep apnoea and cardiovascular disease.

Authors:  G S Hamilton; P Solin; M T Naughton
Journal:  Intern Med J       Date:  2004-07       Impact factor: 2.048

10.  Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension.

Authors:  E C Fletcher; J Miller; J W Schaaf; J G Fletcher
Journal:  Sleep       Date:  1987-02       Impact factor: 5.849

View more
  2 in total

1.  Pregnant women with gestational hypertension may have a high frequency of sleep disordered breathing.

Authors:  John Reid; Robert Skomro; David Cotton; Heather Ward; Femi Olatunbosun; John Gjevre; Christian Guilleminault
Journal:  Sleep       Date:  2011-08-01       Impact factor: 5.849

Review 2.  OSAS and metabolic diseases: Round Table, 99(th) SIO National Congress, Bari 2012.

Authors:  D Passàli; P Tatti; M Toraldo; M de Benedetto; F Peverini; G Caruso; A Marzetti; F M Passàli; L Bellussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.